Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?

Cholesterol is an important component for cell physiology. It regulates the fluidity of cell membranes and determines the physical and biochemical properties of proteins. In the central nervous system, cholesterol controls synapse formation and function and supports the saltatory conduction of action potential. In recent years, the role of cholesterol in the brain has caught the attention of several research groups since a breakdown of cholesterol metabolism has been associated with different neurodevelopmental and neurodegenerative diseases, and interestingly also with psychiatric conditions. The aim of this review is to summarize the current knowledge about the connection between cholesterol dysregulation and various neurologic and psychiatric disorders based on clinical and preclinical studies. J. Cell. Physiol. 232: 281–286, 2017. © 2016 Wiley Periodicals, Inc.

[1]  F. Pfrieger,et al.  Modulation of the Isoprenoid/Cholesterol Biosynthetic Pathway During Neuronal Differentiation In Vitro , 2016, Journal of cellular biochemistry.

[2]  L. Tamm,et al.  The role of cholesterol in membrane fusion. , 2016, Chemistry and physics of lipids.

[3]  M. Mattson,et al.  Probing extracellular Sonic hedgehog in neurons , 2016, Biology Open.

[4]  C. Frost,et al.  A Metabolic Study of Huntington’s Disease , 2016, PloS one.

[5]  I. Kloszewska,et al.  Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. , 2015, Diabetes & metabolic syndrome.

[6]  M. L. Vanzeler,et al.  Statins enhance cognitive performance in object location test in albino Swiss mice: Involvement of beta-adrenoceptors , 2015, Physiology & Behavior.

[7]  Y. Mao,et al.  Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor , 2015, Lipids in Health and Disease.

[8]  A. Hannan,et al.  Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis. , 2015, Journal of Huntington's disease.

[9]  F. Pfrieger,et al.  Cholesterol in brain disease: sometimes determinant and frequently implicated , 2014, EMBO reports.

[10]  Xiaoli Wu,et al.  Age-dependent effect of high cholesterol diets on anxiety-like behavior in elevated plus maze test in rats , 2014, Behavioral and Brain Functions.

[11]  Tsu-Kung Lin,et al.  Simvastatin treatment exerts antidepressant-like effect in rats exposed to chronic mild stress , 2014, Pharmacology Biochemistry and Behavior.

[12]  Oliver Howes,et al.  Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies , 2014, Neuroscience & Biobehavioral Reviews.

[13]  V. Pallottini,et al.  Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline. , 2014, Current medicinal chemistry.

[14]  A. Rodrigues,et al.  Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice , 2014, Pharmacology Biochemistry and Behavior.

[15]  Stuart Maudsley,et al.  Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients , 2014, Front. Physiol..

[16]  J. Connor,et al.  H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment , 2014, Neurobiology of Aging.

[17]  Hansen Wang.  Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders , 2014, Front. Behav. Neurosci..

[18]  A. Manduca,et al.  Simvastatin Treatment Highlights a New Role for the Isoprenoid/Cholesterol Biosynthetic Pathway in the Modulation of Emotional Reactivity and Cognitive Performance in Rats , 2014, Neuropsychopharmacology.

[19]  J. Ruysschaert,et al.  Stereospecific requirement of cholesterol in the function of the serotonin1A receptor. , 2014, Biochimica et biophysica acta.

[20]  A. Francesconi,et al.  Agonist-dependent Signaling by Group I Metabotropic Glutamate Receptors Is Regulated by Association with Lipid Domains* , 2013, The Journal of Biological Chemistry.

[21]  Christie M. Buchovecky,et al.  A suppressor screen in mouse Mecp2 implicates cholesterol metabolism in Rett Syndrome , 2013, Nature Genetics.

[22]  M. Marino,et al.  Analysis of the protein network of cholesterol homeostasis in different brain regions: An age and sex dependent perspective , 2013, Journal of cellular physiology.

[23]  A. Rodrigues,et al.  Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levels , 2013, European Neuropsychopharmacology.

[24]  V. Leoni,et al.  24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. , 2013, Biochimie.

[25]  M. Bear,et al.  Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome , 2013, Neuron.

[26]  Christie M. Buchovecky,et al.  A role for metabolism in Rett syndrome pathogenesis , 2013, Rare diseases.

[27]  J. Ruysschaert,et al.  Stereospeci fi c requirement of cholesterol in the function of the serotonin 1 A receptor , 2013 .

[28]  Christie M. Buchovecky,et al.  A suppressor screen in Mecp 2 mutant mice implicates cholesterol metabolism in Rett syndrome , 2013 .

[29]  A. Chattopadhyay,et al.  Membrane cholesterol stabilizes the human serotonin(1A) receptor. , 2012, Biochimica et biophysica acta.

[30]  Christian Humpel,et al.  Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood–brain barrier leakage in rats in vivo , 2012, Journal of the Neurological Sciences.

[31]  V. Pallottini,et al.  Regulation of cholesterol biosynthetic pathway in different regions of the rat central nervous system , 2012, Acta physiologica.

[32]  Anil Kumar,et al.  Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms , 2012, Brain Research.

[33]  A comparative effect of atorvastatin with other statins in patients of hyperlipidemia , 2012, Indian journal of pharmacology.

[34]  L. McMahon,et al.  Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation , 2012, Neuroscience.

[35]  D. Bansal,et al.  Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies , 2012, Journal of Neurology.

[36]  A. Cavalli,et al.  Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice. , 2012, Journal of pharmacological sciences.

[37]  Lili Yu,et al.  Low cholesterol is associated with depression among US household population. , 2011, Journal of affective disorders.

[38]  B. Golomb,et al.  First-degree relatives with behavioural adverse effects on statins , 2011, BMJ Case Reports.

[39]  M. Marino,et al.  Age‐ and sex‐related differences in extra‐hepatic low‐density lipoprotein receptor , 2011, Journal of cellular physiology.

[40]  E. Cattaneo,et al.  Emerging roles for cholesterol in Huntington's disease , 2011, Trends in Neurosciences.

[41]  M. Mihanović,et al.  Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[42]  A. Troisi.  Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms , 2011, Psychiatry Research.

[43]  A. Bentivoglio,et al.  Whole body cholesterol metabolism is impaired in Huntington's disease , 2011, Neuroscience Letters.

[44]  J. Miles.  Autism spectrum disorders—A genetics review , 2011, Genetics in Medicine.

[45]  H. Hendriksen,et al.  Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats , 2011, Psychopharmacology.

[46]  K. Pahan,et al.  Prospects of Statins in Parkinson Disease , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[47]  Luke Clark,et al.  Serotonin selectively influences moral judgment and behavior through effects on harm aversion , 2010, Proceedings of the National Academy of Sciences.

[48]  M. MacDonald,et al.  Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes , 2010, The Journal of Neuroscience.

[49]  S. Amara,et al.  Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding* , 2010, The Journal of Biological Chemistry.

[50]  B. Schreurs.  The effects of cholesterol on learning and memory , 2010, Neuroscience & Biobehavioral Reviews.

[51]  S. Shrivastava,et al.  Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. , 2010, Biochemistry.

[52]  J. Coid,et al.  Antisocial personality disorder--stable and unstable subtypes. , 2010, Journal of personality disorders.

[53]  D. Sparks,et al.  Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort , 2010, Neurodegenerative Diseases.

[54]  E. Masliah,et al.  Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies , 2010, Experimental Neurology.

[55]  D. Volmer,et al.  Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients , 2009, Neurobiology of Disease.

[56]  S. MacDonald,et al.  Serum total cholesterol, statins and cognition in non-demented elderly , 2009, Neurobiology of Aging.

[57]  J. Dietschy.  Central nervous system: cholesterol turnover, brain development and neurodegeneration , 2009, Biological chemistry.

[58]  S. Tabrizi,et al.  Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. , 2008, Brain : a journal of neurology.

[59]  D. Alkon,et al.  Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks , 2008, European Neuropsychopharmacology.

[60]  E. Masliah,et al.  Statins reduce neuronal α‐synuclein aggregation in in vitro models of Parkinson’s disease , 2008, Journal of neurochemistry.

[61]  Total cholesterol and the risk of Parkinson disease , 2008, Neurology.

[62]  M. Ekinci,et al.  Simvastatin impairs spatial memory in rats at a specific dose level. , 2008, The Tohoku journal of experimental medicine.

[63]  M. Panas,et al.  Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives. , 2008, Molecular genetics and metabolism.

[64]  E. Tierney,et al.  Autism: The role of cholesterol in treatment , 2008, International review of psychiatry.

[65]  Lewis E Kazis,et al.  Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease , 2007, BMC medicine.

[66]  H. Soininen,et al.  Serum cholesterol changes after midlife and late-life cognition , 2007, Neurology.

[67]  A. Convit,et al.  Hypercholesterolemia in Asperger syndrome: Independence from lifestyle, obsessive–compulsive behavior, and social anxiety , 2007, Psychiatry Research.

[68]  Albert Hofman,et al.  Serum cholesterol levels and the risk of Parkinson's disease. , 2006, American journal of epidemiology.

[69]  Richard E Thompson,et al.  Abnormalities of cholesterol metabolism in autism spectrum disorders , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[70]  D. Alkon,et al.  Cholesterol-enriched diet affects spatial learning and synaptic function in hippocampal synapses , 2006, Brain Research.

[71]  R. Lerner,et al.  Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization , 2006, Nature chemical biology.

[72]  S. Lee,et al.  Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease , 2006, Neurochemistry International.

[73]  M. Fava,et al.  A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder , 2006, Journal of clinical psychopharmacology.

[74]  G. Jow,et al.  Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. , 2006, Journal of affective disorders.

[75]  J. Lieberman,et al.  A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls , 2005, Schizophrenia Research.

[76]  G. Turecki,et al.  Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. , 2005, The American journal of psychiatry.

[77]  Ruth A. Carper,et al.  Autism and Abnormal Development of Brain Connectivity , 2004, The Journal of Neuroscience.

[78]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[79]  R. Mckeown,et al.  Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2004, The American journal of clinical nutrition.

[80]  J. Dietschy,et al.  Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. , 2003, Brain research. Developmental brain research.

[81]  L. Dennerstein,et al.  Serum lipids and memory in a population based cohort of middle age women , 2003, Journal of neurology, neurosurgery, and psychiatry.

[82]  Bruno Falissard,et al.  Understanding impulsivity in severe depression? A psychometrical contribution , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[83]  G. Vega,et al.  Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. , 2003, Archives of neurology.

[84]  F. Pfrieger.  Role of cholesterol in synapse formation and function. , 2003, Biochimica et biophysica acta.

[85]  J. Lieberman,et al.  Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. , 2003, The American journal of psychiatry.

[86]  G. Vega,et al.  Reduction in Levels of 24 S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease , 2003 .

[87]  K. Lesch,et al.  Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits , 2003, Journal of Neural Transmission.

[88]  F. Pfrieger.  Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[89]  M. Simmonds,et al.  Effects of membrane cholesterol on the sensitivity of the GABAA receptor to GABA in acutely dissociated rat hippocampal neurones , 2001, Neuropharmacology.

[90]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[91]  Joseph L. Goldstein,et al.  The Cholesterol Quartet , 2001, Science.

[92]  M. Brown,et al.  Molecular medicine. The cholesterol quartet. , 2001, Science.

[93]  Jean-Marc A. Lobaccaro,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .

[94]  L. G. Almeida-Montes,et al.  Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. , 2000, Journal of psychiatry & neuroscience : JPN.

[95]  I. Shimomura,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. , 2000, Genes & development.

[96]  G. Snipes,et al.  COMMON THEMES IN PERIPHERAL NEUROPATHY DISEASE GENES , 1998, Cell biology international.

[97]  D. Lütjohann,et al.  Importance of a Novel Oxidative Mechanism for Elimination of Brain Cholesterol , 1997, The Journal of Biological Chemistry.

[98]  G Salen,et al.  Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) , 1997, American journal of medical genetics.

[99]  D. Lütjohann,et al.  Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[100]  A. Hoes,et al.  Low serum cholesterol concentration and serotonin metabolism in men , 1996, BMJ.

[101]  M. Irons,et al.  Abnormal cholesterol metabolism in Smith‐Lemli‐Opitz syndrome , 1995, Current opinion in pediatrics.

[102]  D. Goldman,et al.  Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. , 1995, Journal of psychiatry & neuroscience : JPN.

[103]  J. Kleinman,et al.  Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics , 1993, Neuropsychopharmacology.

[104]  G. Nadeau,et al.  Further study of blood cholesterol in schizophrenia. , 1952, Canadian Medical Association journal.